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ABSTRACT  Previous studies have shown that the senescent phenotype is dominant with respect 
to  DNA  synthesis in  fusions  between  late  passage and  actively  replicating  human  diploid 
fibroblasts.  Brief  postfusion  treatments  with  the  protein  synthesis  inhibitor cycloheximide 
(CHX) or puromycin have been found to significantly delay (by 24-48 h) the inhibition of entry 
into  DNA  synthesis of  young  nuclei  in  heterokaryons  after  fusion  with  senescent  cells.  A 
significant fraction  of  the senescent  nuclei  incorporated  tritiated  thymidine  in  CHX-treated 
heterokaryons. The optimal duration of exposure to CHX was I-3 h immediately after fusion, 
although  treatments  beginning as late as 9 h after fusion elevated  the heterokaryon  labeling 
index.  Prefusion  treatments  with  CHX  were  without  a  significant  effect.  These results  are 
consistent with the interpretation that regulatory cell  cycle  inhibitor(s) which are dependent 
upon  protein  synthesis  may  be  present  in  heterokaryons  between  senescent  and  actively 
replicating cells. 
The ffmite in vitro replicative lifespan of human diploid fibro- 
blastlike (HDFL) cells has been well documented (1, 2). Studies 
have demonstrated that the proportion ofnondividing or slowly 
cycling cells increases with serial passage until the entire pop- 
ulation becomes arrested predominantly in the GI phase of the 
cell cycle (3, 4). The mechanism(s) responsible for limiting the 
growth potential remains unclear. Rabinovitch and Norwood 
(5) and Stein and Yanishevsky (6) have proposed that cessation 
of proliferation or "senescence"  results from the constitutive 
synthesis  of an inhibitory factor(s).  This hypothesis is based 
primarily upon observations derived  from cell fusion studies 
carried out in these laboratories. These investigators observed 
that initiation of DNA synthesis in the young, actively prolif- 
erating  cell  is  inhibited  in  heterokaryons  after  fusion  with 
senescent  HDFL cells,  but  ongoing DNA synthesis was not 
inhibited.  In addition, Rabinovitch and Norwood (5) demon- 
strated that inhibition  of entry into DNA synthesis occurs if 
fusion with a senescent cell is complete while the young nucleus 
is in the G1 phase of the cell cycle at a point earlier than 3 h 
before the onset of the S phase. Similar results were observed 
in parallel studies where actively proliferating HDFL cells were 
fused with cells rendered quiescent by serum deprivation (5). 
While the proposal that senescent and quiescent ceils elaborate 
a cell cycle inhibitory factor(s) is a reasonable interpretation of 
these observations, alternative hypotheses cannot be excluded. 
For example, it is possible that fusion between actively prolif- 
erating low passage and late passage senescent cells results in 
dilution  of factors  necessary  for cell  cycle progression  and 
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initiation of DNA synthesis, resulting in passive inhibition of 
DNA synthesis. 
We further investigated  these alternative interpretations  in 
studies  in which the effect of transient  inhibition  of protein 
synthesis on DNA synthetic activity was examined in hetero- 
karyons between  old  and  young HDFL ceils.  We  observed 
inhibition of entry into DNA synthesis of young nuclei upon 
fusion with senescent cells to be significantly delayed by brief 
treatments with protein synthesis inhibitors.  These results are 
interpreted to be consistent with the presence of a regulatory 
inhibitor of cell cycle function in the 'senescent cell. 
MATERIALS  AND  METHODS 
Cells and Culture Conditions 
HDFL cells described in these studies were initiated in this laboratory from 
primary explants. The sources, population doubling levels, and labeling indices 
of these strains are described in Table I. 
Cells were maintained in Eagle's minimum essential  medium (EMEM) with 
Earle's Salts  (Gibco Laboratories, Grand Island Biological  Co., Santa Clara, 
CA),  buffered with 26 mM sodium bicarbonate, supplemented with 10% heat- 
inactivated  fetal bovine serum (Oibco Laboratories; and Reheis Chemical Co., 
Div. Armour Pharmaceutical Co., Kankakee, IL), penicillin  (100 U/ml), strep- 
tomycin (100 #g/ml), and incubated at 37"C in an atmosphere of 5% CO2 in air. 
Early passage cells  were maintained in an actively  cycling  state by passaging 
twice  a  week.  Tests for mycoplasma by aerobic and anaerobic cultures were 
negative (7). 
Cell Fusion Procedure 
To facilitate  identification of heterokaryons, the early passage, actively prolif- 
erating HDFL cells  were prelabeled for 24 h  with 2.5 gCi/ml |3H]methionine 
187 TABLE  I 
Origin and In Vitro Age of Cell Strains Used in These Studies 
Strain  Source 
No. of  [aH]Thy- 
popula-  midine- 
tion dou-  labeling 
blings*  index:t: 
Early passage 
76-109  Newborn foreskin  14 (70)  94 
75-69  Newborn  foreskin  7 (58)  87 
75-73  Fetal upper arm skin  18 (59)  92 
72-166  Adult  upper arm skin  8  (58)  90 
Late passage 
72-117  Adult  upper arm skin  60 (60)  <5 
75-69  Newborn foreskin  56 (58)  <5 
72-166  Adult upper arm skin  58 (58)  <5 
* These  strains  were used at the  indicated  population doublings from  the 
time of the initial passage after explanation. The maximum lifespan is shown 
in parentheses. 
The percentage of labeled cells in subconfluent cultures after a 24-h  pulse 
with  [aH]thymidine (0.5 #Ci/ml). 
(L-[methyl-aH]-methionine, sp act 200 mCi/mM; New England Nuclear, Boston, 
MA) and 0.9-tma diameter latex beads (Polysciences, Inc., Warmgton, PA). This 
prelabeling protocol was not observed to affect the proportion of [aH]thymidine- 
labeled cells in  actively cycling HDFL  cultures during  the  labeling periods 
described in these experiments. The senescent cells were prelabeled for 24 h with 
2.0-/an latex beads. At the termination of the prelabeling procedure the cultures 
were trypsinized, rinsed free of extracellular beads by three successive washes 
using 1,000-g centrifugation, and plated on 25-mm round plastic cover slips (Lux 
Scientific Corp., Naperville, IL) in 35-mm petri dishes (Coming Glass Works, 
Scientific Products Div., Coming, NY) at a density of -12,000 of each c¢11 type 
per cover slip. This procedure results in a partial synchrony of DNA synthesis 
over the  following 24-h  period  in young ceils. After  allowing for  overnight 
attachment (~ 16 h), the cells were fused by a I-rain exposure to 44% polyethylene 
glycol (PEO) (1,000  mol wt; Koch-Light Laboratories Ltd., Research Products 
International, Mt. Prospect, IL) dissolved in serum-free medium containing 10% 
dimethyl sulfoxide (DMSO;  Schwarz/Mann  Div.,  Becton,  Dickinson &  Co., 
Orangeburg,  NY),  immediately followed by  three  successive rinses in  10% 
DMSO-EMEM,  and a  single wash with medium containing 10% fetal bovine 
serum. The cultures were then exposed to medium containing cycloheximide 
(CHX;  Sigma Chemical Co.,  St.  Louis,  MO)  or  puromycin dihydrochloride 
(Sigma Chemical Co.) at the concentrations and durations of exposure indicated, 
and, following removal of the inhibitors, the cultures were rinsed three times with 
Hanks' Balanced Salt Solution (HBSS; Oibco Laboratories). The cultures were 
then pulsed with [aH]thymidine (0.5  #Ci/ml, S.A.-6.7  Ci/mM; New England 
Nuclear) at various times and for various durations after treatment with the 
inhibitors, depending upon the experimental situation. Details of the various 
[~H]thymidine pulse schedules are described in the figure legends. At the end of 
each pulse period, the cover slips were washed three times in phosphate-buffered 
saline, fLxed for 24 h  in Bouin's fluid, and processed for autoradiography as 
previously described (8). 
Experiments in which cultures were exposed to the inhibitor before fusion 
were performed as described above, except that young and senescent HDFL cells 
were co-cultivated, treated with the inhibitor for various durations of exposure, 
and rinsed three times with HBSS immediately before fusion. 
Experiments involving CHX  treatment  of only the senescent cells before 
fusion were accomplished via a  Sandal virus-mediated fusion protocol as de- 
scribed previously (9). Briefly, senescent ceils were plated at a density of 12,000/ 
25-ram cover slip, treated with CHX  for various durations of exposure, and 
rinsed three times with HBSS before the addition of UV-inactivated Sendal virus 
(200 HALl) and 12,000 young cells. The cultures were maintained at 4°C for 20 
min, incubated at 37°C for 60 min, rinsed once with HBSS,  and pulsed with 
[aH]thymidine (0.5 #Ci/ml) for three consecutive 24-h pulse periods. The Sendal 
virus was kindly provided by Dr. H. Harris, Oxford University, Oxford, England. 
The  autoradiographs were screened at  x  500  magnification under  an oil 
immersion lens. Subcontinent areas of the preparations were analyzed where 
heterokaryons could be unambiguously identified. Heterokaryons were defined 
as hi- and multinucleate cells containing ten or more beads of each size and 
methionine label Before analysis, all preparations were screened for bead con- 
tamination, and those with excessive numbers of extracellular beads and/or 
inappropriate labeling by the beads in monokaryons were excluded from the 
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analysis. To minimize the possibility of observer bias, randomly selected prepa- 
rations were analyzed by another individual familiar with the prelabellng system. 
The percentage of labeled nuclei in the homodikaryons and heterodikaryons 
were calculated by dividing the number of [aH]thymidine-labeled nuclei by the 
total number of nuclei multiplied by 100. 
Measurements of Amino Acid and 
Thymidine Incorporation 
The kinetics of recovery of protein and DNA synthesis were determined after 
treatment with CHX and puromycin. In these studies, ~1 x  l0  s cells were plated 
into 60-mm tissue culture dishes (Coming Glass Works), and, after overnight 
attachment, some dishes were treated with medium containing CHX or puro- 
mycin for  1 h. The medium was then aspirated, the dishes were rinsed three 
times with HBSS, and medium lacking inhibitors was added. At various times 
after release, replicate cultures were pulsed for I h with [3Hlmethionine (4 ~Ci/ 
ml,  S.A.-200  mCi/mM, New  England Nuclear) for  determination of protein 
synthesis or with [3H]thymidine (10 #Ci/ml, S.A.-6.7  Ci/mM,  New England 
Nuclear) for determination of DNA synthesis. Immediately after the pulse, the 
cells were rinsed three times in ice-cold phosphate-buffered saline, dissolved in 
l ml of 1% (wt/vol) SDS (Bio-Rad Laboratories, Richmond, CA) containing 100 
#g/ml carrier DNA  (Type  l:  calf thymus DNA;  Sigma Chemical Co.),  and 
precipitated with 0.5  ml of ice-cold 50%  TCA.  The  precipitate was pelleted, 
resnspended in  l  ml of 0.3  N  NaOH,  and re-precipitated with 0.5  ml of 50% 
TCA two more times before adding l ml of 0.1 N NaOH and incubating at 60°C 
for  10 min. The solution was placed in a scintillation vial in 10 ml of Aquasol 
(New England Nuclear), with 75/~1 of acetic acid, and counted on a  Packard 
Tricarb  liquid scintillation counter  (Packard  Instrument Co.,  Inc.,  Downers 
Grove, IL). To obtain baseline values of amino acid incorporation in the presence 
of inhibitor, cultures were exposed to CHX or puromycin simultaneously with 
[aH]methionine for I h, and immediately rinsed and dissolved in SDS. 
Cell counts were obtained from  duplicate dishes using a  Coulter Counter 
(Coulter Electronics Inc., Hialeah, FL). 
RESULTS 
Initial studies were performed to determine the effect of a short 
postfusion treatment with CHX on the nuclear [3H]thymidine 
labeling index in heterodikaryons at various times after release 
from the protein synthesis inhibitor. A concentration was used 
which inhibits protein synthesis by >98%  (10 #g/ml).  A  rep- 
resentative result from multiple experiments is shown in Fig. 
1. As we have observed in previous studies (5), the fraction of 
[3H]thymidine-labeled  nuclei  in  heterodikaryons  in  the  un- 
treated cultures began to decline after a 3-h delay after fusion, 
and by 9  hs it was similar to that enumerated in old homodi- 
karyons  (Fig.  I a).  In  contrast,  the  heterodikaryon  labeling 
index in the CHX-treated cultures was elevated throughout the 
labeling period, while the young and old homokaryon labeling 
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(A)  and with  exposure (8)  to 
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'  '  B'  fused  with  senescent  fibro- 
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midine  (10  #Ci/ml)  at  the 
times  indicated  after  fusion. 
~  o  The  experimental  cultures 
were  exposed  to  CHX  (2  p,g/ 
ml)  for  I  h  immediately  after 
fusion, and pulsed for I  h with 
[aH]thymidine  at the times in- 
dicated. The results shown are 
from  a  representative  experi- 
(E3)  heterodikaryons;  (A)  old 
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ment.  (O)  young  homodikaryons; 
homodikaryons. indices  were  unaffected  by  the  treatment  (Fig.  I b).  In  the 
absence  of markers the  parental  origin  of the  nuclei  in the 
heterokaryons cannot be identified.  However, the fraction of 
heterokaryons with both nuclei labeled provides an estimate of 
the  extent  to  which  thymidine  incorporation  occurs  in  the 
senescent nuclei.  In all cell strains examined in this study the 
proportion of double-labeled heterodikaryons was significantly 
increased in the CHX-treated cultures (Table II). 
To  determine  whether  the  elevation  in  the  heterokaryon 
labeling index observed following postfusion CHX treatment 
was specifically the result of inhibition of protein synthesis or 
an action unique to CHX, studies were conducted using puro- 
mycin, which has a different mode of action than CHX (10). 
Dose-response  studies  carried  out with  both  inhibitors  dem- 
onstrated that similar results were obtained when the cultures 
were treated with puromycin after fusion (Fig. 2). An approx- 
imate linear increase in the percentage of labeled heterokaryons 
was observed with a  1-h postfusion treatment, correlating with 
exponential increases in the concentration of CHX in the range 
of 0.05 to 2 gg/ml and with puromycin in the range of 1 to 50 
/~g/ml. 
The degree of inhibition of protein synthesis corresponding 
to these concentrations of inhibitors was determined by liquid 
scintillation  counting  of  [3H]methionine  incorporation  into 
acid-precipitable material (Fig. 3). Increased concentrations of 
inhibitors  resulted  in  an  increased  inhibition  of amino  acid 
uptake in both young and senescent cultures. A  1-h exposure 
TABLE  II 
Percentage of Heterodikaryons  with 0,  1, or 2  [3H]Thymidine- 
labeled  Nuclei 
Without  CHX  With  CHX 
Cell cross 
(young  X  senescent)  0  1  2  0  1 
76-109 x  75-69*  77  14  9  41  25  34 
76-109 x  72-16@I:  99  I  0  63  25  12 
75-73 x  72-166  90  7  3  59  19  22 
75-69 x  75-69  73  7  20  36  17  47 
72-166 x  72-117~:  82  10  8  42  20  38 
The effect of CHX on the proportion of labeled nuclei in heterodikaryons. 
Actively proliferating and senescent HDFL cells were fused, treated with 10 
/~g/ml  of CHX for 1 h, and pulsed with 0.5/LCi/ml of [3H]-Thymidine for 24 
h after release from the inhibitor. An average of 75-100 heterokaryons was 
counted for each determination. 
* Average values from three separate experiments. 
Average values from two separate experiments. 
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The effect of various concentrations  of CHX or puromy- 
cin  on  the  [3H]thymidine-labeling  indices  in  heterodikaryons  be- 
tween  early and  late passage cells. Strain  75-73  (PD 18) and 72-117 
(PD 60)  were fused,  treated  for  1  h  immediately  after  fusion  with 
puromycin  (A)  or  CHX  (8)  at  the  concentrations  shown,  then 
immediately  pulsed  for 24 h  with  [aH]thymidine  (0.5 p.Ci/ml),  and 
processed  for autoradiography. 
120 
80 
.c  ;. o.ol 
g 
:~  4010.05~ 
(0.2p 
(0.5h 
,.~  (2)' 
E  e~ 
o 
2 
~  120 
o 
I- 
p 
~  80 
40  (t 
(10), 
(50), 
(100)' 
A 
,,, 
(0.5 
(2), 
i  !  i 
C 
B  ~,  ./  "\ 
..  7/  f/"  "~ 
i  i  i 
=%  (0.05), 
•  ............  ,0,_ 
"  t  .,  "..~..-"  s 
:  /.  "-,.  (0.S), 
I ~',  "o- ....... ..e 
121, 
Ill  \  x 
~  ll  \  "~-  I  / 
i  !  1  i  i  i 
2  6  10  2  6  10 
Hours after release 
FiGure  3  Recovery of [3H]methionine  incorporation  into acid-pre- 
cipitable  material  after release from cycloheximide  or puromycin  in 
early  and  late  passage  HDFL  cells.  Details  of  the  procedure  are 
described in the text. Concentrations  of the inhibitors  are shown  in 
parentheses on the vertical axis of each graph.  Strains 75-73 (PD 18) 
and  72-117 (PD 60) were exposed to CHX at 0.01, 0.05, 0.2, 0.5, and 
2 #g/ml  for I  h  before release from  the inhibitor  (A  and  B, respec- 
tively).  Strain  75-73  was  treated  with  I,  10,  50,  and  100  #g/ml 
puromycin  (C), and Strain 72-117 with 0.1, 0.05, 0.5, 2, and 8 p,g/ml 
puromycin  (D)  for I  h. All counts were performed  in duplicate  and 
were  standardized  per  10  ~ cells  before  calculating  the  values  for 
percent control. 
to  10  /.tg/ml  puromycin  or  2  /tg/ml  CHX  was  sufficient  to 
reduce  [3H]methionine  incorporation  by  -90%.  Recovery of 
synthetic  activity  was  observed  to  be  90-100%  of  controls 
within 2 h in both early and late passage cultures. No consistent 
significant  differences were observed in the kinetics or extent 
of recovery after treatment with CHX at the various concen- 
trations  (Fig.  3a  and  b).  In  contrast,  treatment  of  young 
cultures with concentrations of puromycin necessary to inhibit 
[aH]methionine  uptake  by  >90%  (50-100  /~g/ml)  and  maxi- 
mally stimulate DNA synthesis in heterokaryons resulted in a 
significantly  decreased  recovery  in  the  incorporation  of the 
labeled precursor, which is in agreement with a previous report 
(11)  (Fig.  3c).  A  large  proportion  of cells,  exposed  to  the 
highest concentration, were judged nonviable by their inability 
to exclude  trypan blue dye.  Similar  studies  carded  out with 
senescent  cells  at concentrations  of puromycin of <I0/~g/ml 
displayed complete  recovery of incorporation  of [3Hlmethio- 
nine (Fig. 3 d). 
The kinetics of recovery of protein synthesis as a function of 
duration  of exposure to CHX  (2 or  10 jag/ml)  in young and 
senescent  cultures  was  also  examined.  No  differences  were 
observed in cultures exposed from 1 to 24 h (data not shown). 
Recovery of DNA synthesis in young cultures as assessed by 
[aH]thymidine  incorporation  into  acid-precipitable  material 
was also observed to be independent of the concentration  of 
CHX used  in these  studies  (Fig.  4).  Within  4  h  after release 
from CHX,  the cultures  had recovered to within  80% of the 
values for untreated controls. 
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synthesis on the DNA synthetic activity in these heterokaryons, 
the effect of duration of exposure to CHX immediately after 
fusion was examined (Fig. 5).  Exposure periods of 1 to 3  h 
resulted in the greatest elevation of the nuclear thymidine in 
the heterokaryons. Increasingly lowered values were observed 
with longer exposure periods. Treatment periods of 15  or 30 
min produced no elevation in the fraction of labeled nuclei in 
these cells (data not shown). 
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FIGURe  4  Recovery of  [3H]thymidine  ([aH]Tdr in figure)  incorpo- 
ration after release from various concentrations of CHX. Strain 75-73 
at early passage (PD 18) was exposed to 0.2  (11), 0.5  (A), 2 (0), and 
10 (A) #g/ml CHX for I  h. At the times after release indicated in the 
figure, cultures were pulsed with 4 #Ci/ml of [aH]thymidine for I  h. 
All  determinations represent the mean value of duplicate counts, 
standardized to 10  s cells. 
The time of initiation of the CHX treatment in relation to 
cell fusion proved to be a significant variable. Exposure for 3- 
h intervals within the first 24 h  after fusion resulted in eleva- 
tions in the [3H]thymidine labeling index in the heterokaryons 
(Fig. 6 b, c, and d). Stimulation of thymidine incorporation was 
observed when the treatment was initiated as late as 9 h  after 
fusion. When the protein synthesis inhibitor was introduced at 
24  h  after  fusion  for  either  3-  (Fig.  6e)  or  12-h  (Fig. 6f) 
intervals, no increase in the: fraction of labeled nuclei in the 
heterokaryons was observed. Note also that the labeling index 
remains  elevated for  at  least 24  h  after  termination  of the 
treatment with the inhibitor. 
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FIGUR[  6  [aH]thymidine-labeling index of heterodikaryons treated 
with  CHX  at various times after fusion.  Strains 76-109 and 72-166 
were exposed to 2/Lg/ml CHX at 0-3 h  (B), 3-7 h  (C), 9-12 h  (D), 
24-27  h  (E)  and  24-36  h  (F)  after fusion,  and  pulsed  with  [3H]- 
thymidine (0.5 #Ci/ml) for three consecutive 24-h periods beginning 
50-  immediately after release from  the inhibitor.  Control cultures  (A) 
which were not treated with CHX were pulsed with  [3H]thymidine 
immediately  after  fusion.  ([El, Y)  young  homodikaryons;  (O,  O) 
senescent homodikaryons; (0,  H)  heterodikaryons. 
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FtOUR[  5  The effect of durations of exposure to CHX, immediately 
after cell fusion, on the [3H]thymidine-labeling indices in hetero- 
dikaryons derived from the fusion of a variety of strains of human 
diploid cells. Actively proliferating cells were fused with senescent 
cells, treated with 2/~g/ml  CHX for various durations of exposure, 
and  pulsed with  [aH]thymidine (0.5 #Ci/ml)  for 24 h  immediately 
after release from the inhibitor. The values plotted at 0  h  indicate 
heterodikaryon labeling indices of untreated cultures.  (O) 76-109 x 
72-117; (O) 76-109 x  72-166; (A) 75-73 x  75-69; (0) 76-109 X  75-69; 
(R)  76-109 X  75-69; (A) 75-73 x  72-166 (young x  senescent). 
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FIGUR[  7  The effect  of  prefusion  treatment with  CHX  of various 
durations  on  the  heterodikaryon  [aH]thymidine-labeling  index. 
Young, actively proliferating, and senescent cells of various strains 
were cocultivated and exposed to CHX for the durations indicated 
on the horizontal axis.  The cultures were immediately fused  after 
removal of the inhibitor and then pooled with  [aH]thymidine (0.5 
#Ci/ml) for 24 h. In the cross 76-109 x  72-166 (open circles) only the 
senescent cells were treated with CHX. (A) 72-166 X 72-117; (0) 76- 
109 X 75-69; (~  76-109 X 75-69; (A) 76-109 X 75-69; ([~) 75-69 X 75- 
69; (O) 76-109 X 72-166 (young X  senescent). 
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labeling  indices  observed  with  postfusion  CHX  treatments, 
exposures of both young and senescent cells to the inhibitor 
for various durations before fusion did not result in significant 
increases in the percentage of labeled heterokaryons (Fig. 7). 
Similarly,  prefusion  treatment  of senescent  ceils  alone  with 
CHX for various durations of exposure had no effect on the 
subsequent heterokaryon labeling index (Fig. 7, open circles). 
DISCUSSION 
The experiments described here have demonstrated that brief 
treatments  with  protein  synthesis  inhibitors  after cell  fusion 
results in a significant but temporary elevation of the nuclear 
thymidine-labeling  index  in heterokaryons derived  from the 
fusion of young, actively proliferating,  and senescent human 
diploid cells.  The transient nature of this effect (24-48 h) and 
the observation that introduction of the inhibitors  24 h  after 
fusion fails to stimulate nuclear thymidine incorporation in the 
heterokaryons suggest that inhibition of protein synthesis per- 
mits the young nuclei to progress into the S phase in the hybrid 
environment but does not stimulate  sustained sequential cell 
cycle activity. In addition, the increased frequency of hetero- 
karyons with both nuclei labeled  after treatments  with these 
inhibitors indicates a modest stimulation of initiation of DNA 
synthesis  in the  senescent  nuclei.  Identical  results  have  also 
been observed in parallel experiments using Sendal virus as a 
fusogen (results not shown), demonstrating that the stimulatory 
effects of postfusion treatments with protein synthesis inhibi- 
tors were not specific to the polyethylene glycol (PEG)-medi- 
ated fusion protocol. 
The elevation in the heterokaryon labeling index after treat- 
ment with  CHX or puromycin correlated with the degree of 
inhibition of protein synthesis (as measured by the incorpora- 
tion of [3H]methionine) produced by different concentrations 
of the inhibitors.  Also, treatments  of <1  h  (15  and  30 rain) 
produced no effect on the [3H]thymidine labeling indices. These 
results are consistent with the interpretation  that a labile fac- 
tor(s) dependent upon protein synthesis may be involved in the 
inhibition  of DNA synthesis  in  heterokaryons  derived  from 
fusions between senescent and actively replicating human dip- 
loid ceils.  The DNA synthesis-inhibiting activity becomes in- 
sensitive to interruption of protein synthesis if the introduction 
of CHX is delayed by at least 24 h after fusion. This suggests 
this product(s) of protein synthesis is not required once inhi- 
bition of DNA synthesis is completed. 
CHX has been shown to produce a reduction in the rate of 
DNA replication in cultured mammalian cells (12-14). Thus, 
it is possible that these results could reflect a prolonged residual 
recovery from the action of the inhibitor on the young nucleus 
and not a real increase in the fraction of labeled heterokaryons. 
However, this interpretation appears to be unlikely in view of 
our observation that recovery of [3H]thymidine incorporation 
was  complete  within  3-4  h  after  release  from treatment  in 
actively cycling early passage ceils  (Fig. 4).  This is consistent 
with the rapid recovery of DNA synthesis reported by other 
investigators  after withdrawal  of this  inhibitor  from cells  in 
early S phase (15-18). 
Several investigators have hypothesized the presence of an 
inhibitor(s) of DNA synthesis which acts to block entry into S 
phase in senescent cells (5, 6, 19). This idea is further supported 
by reconstruction experiments between cytoplasts derived from 
senescent  ceils  and  karyoplasts  (nuclei)  from  early  passage 
cells.  The reconstructed  cells  formed from these  fusions are 
incapable of extended rephcative activity, which is consistent 
with the idea that a diffusible cytoplasmic regulatory inhibitor 
may be present in late passage cytoplasts (20).  However, it is 
unlikely that protein regulatory inhibitors are solely responsible 
for preventing senescent cells  from initiating DNA synthesis. 
Stimulation  of entry  into  S  phase  was  never  observed  in 
senescent  monokaryons or  homokaryons after  release  from 
prolonged treatments  with  CHX, although recovery of [ZH]- 
methionine  uptake  was  rapid  under  these  conditions.  The 
presence  of a  positive  regulatory factor(s)  from the  actively 
repticating  parental  cells  is apparently  necessary for the  in- 
duced stimulation  of DNA synthesis in senescent nuclei ob- 
served in a small fraction of double-labeled heterokaryons after 
inhibition of protein synthesis (Table II). 
A somewhat surprising observation was that treatment with 
CHX immediately before fusion had minimal, if any, effect on 
the post-treatment  [3H]thymidine-labeling indices in the het- 
erokaryons. The interpretation of this result is not clear at the 
present  time.  However, as indicated  in Results,  the putative 
inhibitor(s) must be depressed for at least 1 h. If the half-life of 
the affector molecule(s) is significantly shorter than  1 h, then 
functional levels may be restored rapidly enough to achieve 
inhibition  of DNA synthesis  in  the  heterokaryons.  Alterna- 
tively,  a  unique  fusion  specific product which  is  dependent 
upon polypeptide synthesis may be produced by the hetero- 
karyons immediately after fusion. 
While a number of investigators have postulated the presence 
of an inhibitor(s) of DNA synthesis to explain the mechanism 
of inhibition  of DNA  synthesis  in  heterokaryons  between 
senescent and low passage, actively dividing HDFL cells, there 
are other interpretations of this observation. It is possible that 
initiation factors present in the young cell are diluted below a 
minimum-required  threshold  after  fusion.  The  results  pre- 
sented here are inconsistent with the latter hypothesis, which 
would not predict that inhibition  of protein  synthesis would 
elevate  the  [3H]thymidine-labeling indices  in  the  heterokar- 
yons. However, transient elevations of protein synthesis above 
pretreatment values following recovery from exposure to CHX 
have been reported in cultured primary chick cells and in vivo 
(21,  22).  It is  possible  that  activators of DNA synthesis are 
synthesized in excess immediately after release from inhibition 
o f protein synthesis, resulting in the initiation of DNA synthesis 
in a larger fraction of heterokaryons. Although we were unable 
to consistently observe this overshoot of protein synthesis in 
our monokaryon cultures after CHX treatment,  this interpre- 
tation cannot be ruled out on the basis of our studies. 
In addition to its dramatic inhibitory effect on protein syn- 
thesis,  CHX has also been shown to inhibit  both basal  and 
induced autophagic proteolysis in cultured cells  (23-25).  An- 
other possible explanation for our results is that CHX treatment 
produces an increase in the turnover time of the polypeptide 
initiation  factors in the young cell.  This might stimulate  the 
heterokaryons to progress through one round of DNA synthe- 
sis. 
While studies presented in this paper are consistent with the 
interpretation that an inhibitor(s) is involved in the regulation 
of cell cycle activity in human diploid cells  derived from the 
skin,  clearly  this  hypothesis  can  be  confirmed  only by the 
isolation  and  biochemical  characterization  of this  factor(s). 
This will require the development of suitable bioassays for this 
factor(s).  We  are  currently  attempting  to  develop  an  assay 
system which will detect physiologic inhibition  of cell cycle 
activity by polypeptides. Manual microinjection may provide 
BURMER  EI  At.  Polypeptide-mediated Inhibition  of Cell-cycle Transit  191 a  potential technical approach to the development of such a 
bioassay system for these putative regulatory peptides. 
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